Recruiting NA Cerebral Palsy, Spastic

New treatment option for Cerebral Palsy, Spastic

Official title Effects of Botulinum Toxin Injection Combined with RESWT in Lower Extremity Spasticity in Children with Cerebral Palsy

ClinicalTrials.gov ID: NCT06494618

What this study is testing

What it's testing
This study aimed to check and compare the effects of botulinum toxin injection combined with shock wave therapy versus botulinum toxin injection only for lower extremity spasticity in children with cerebral palsy

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 2 to 18

You may be able to join if

  • Diagnosed with cerebral palsy.
  • Spasticity in at least one of the lower extremity muscle groups.
  • No contraindications to shockwave therapy.
  • Applied Botulinum Toxin Type A injection for at least one spastic muscle of lower extremity.
  • Agreed to participate to study (patient/primary caregiver)

You likely can't join if

  • Surgery history within the last year of the muscle to be injected and treated
  • Having uncontrolled epilepsy.
  • Having infection
  • Coagulopathy

The study team makes the final eligibility decision.

Where it's taking place

  • Istanbul, Kadikoy, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 2 years to 18 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Istanbul, Kadikoy, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.